Cite
HARVARD Citation
Jung, J. et al. (n.d.). PIN-A1, a novel Casein Kinase 1α-selective molecular glue degrader, demonstrates strong antitumor activity via activation of the p53 pathway in preclinical models of AML with a favorable safety profile. European journal of cancer. pp. S20-. [Online].